Abstract
Purpose
The prevalence of metastatic epidural spinal cord compression (MESCC) is increasing globally due to advancements in cancer diagnosis and treatment. Whilst surgery can benefit specific patients, the complication rate can reach up to 34%, with limited reporting on their impact in the literature. This study aims to analyse the influence of major complications on the survival of surgically treated MESCC patients.
Methods
Consecutive MESCC patients undergoing surgery and meeting inclusion criteria were selected. Survival duration from decompressive surgery to death was recorded. Perioperative factors influencing survival were documented and analysed. Kaplan–Meier survival analysis at one year compared these factors. Univariate and multivariate Cox proportional hazard regression analyses were performed. Additionally, univariate analysis compared complicated and uncomplicated groups.
Results
Seventy-five patients were analysed. Median survival for this cohort was 229 days (95% CI 174–365). Surgical complications, low patient performance, and rapid primary tumour growth were significant perioperative variables for survival in multivariate analyses (p < 0.001, p = 0.003, and p = 0.02, respectively) with a hazard ratio of 3.2, 3.6, and 2.1, respectively. Univariate analysis showed no variables associated with complication occurrence.
Conclusion
In this cohort, major surgical complications, patient performance, and primary tumour growth rate were found to be independent factors affecting one year survival. Thus, prioritizing complication prevention and appropriate patient selection is crucial for optimizing survival in this population.
Similar content being viewed by others
Data Availability
The data that support the findings of this study are available from the corresponding author, [MC], upon reasonable request.
References
Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243s–6249s. https://doi.org/10.1158/1078-0432.CCR-06-0931
Macedo F, Ladeira K, Pinho F et al (2017) Bone metastases: an overview. Oncol Rev. https://doi.org/10.4081/oncol.2017.321
Ortiz Gómez JA (1995) The incidence of vertebral body metastases. Int Orthop 19:309–311. https://doi.org/10.1007/BF00181116
Al-Qurainy R, Collis E (2016) Metastatic spinal cord compression: diagnosis and management. Br Med J i2539. https://doi.org/10.1136/bmj.i2539
Patchell RA, Tibbs PA, Regine WF et al (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. The Lancet 366:643–648. https://doi.org/10.1016/S0140-6736(05)66954-1
Miranda SP, Sullivan PZ, Albayar A et al (2023) Preoperative predictors of survival in patients with spinal metastatic disease. Int J Spine Surg 17:557–563. https://doi.org/10.14444/8444
Finkelstein JA, Zaveri G, Wai E et al (2003) A population-based study of surgery for spinal metastases. Survival rates and complications. J Bone Joint Surg Br 85:1045–1050. https://doi.org/10.1302/0301-620x.85b7.14201
Arrigo RT, Kalanithi P, Cheng I et al (2011) Predictors of survival after surgical treatment of spinal metastasis. Neurosurgery 68:674–681. https://doi.org/10.1227/NEU.0b013e318207780c
Kim CH, Chung CK, Jahng T-A, Kim HJ (2011) Resumption of ambulatory status after surgery for nonambulatory patients with epidural spinal metastasis. Spine J 11:1015–1023. https://doi.org/10.1016/j.spinee.2011.09.007
Bollen L, de Ruiter GCW, Pondaag W et al (2013) Risk factors for survival of 106 surgically treated patients with symptomatic spinal epidural metastases. Eur Spine J 22:1408–1416. https://doi.org/10.1007/s00586-013-2726-4
Quraishi NA, Rajagopal TS, Manoharan SR et al (2013) Effect of timing of surgery on neurological outcome and survival in metastatic spinal cord compression. Eur Spine J 22:1383–1388. https://doi.org/10.1007/s00586-012-2635-y
Vanek P, Bradac O, Trebicky F et al (2015) Influence of the preoperative neurological status on survival after the surgical treatment of symptomatic spinal metastases with spinal cord compression. Spine 40:1824–1830. https://doi.org/10.1097/BRS.0000000000001141
Park S-J, Lee C-S, Chung S-S (2016) Surgical results of metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC): analysis of functional outcome, survival time, and complication. Spine J 16:322–328. https://doi.org/10.1016/j.spinee.2015.11.005
Nater A, Tetreault LA, Kopjar B et al (2018) Predictive factors of survival in a surgical series of metastatic epidural spinal cord compression and complete external validation of 8 multivariate models of survival in a prospective North American multicenter study. Cancer 124:3536–3550. https://doi.org/10.1002/cncr.31585
Feng J-T, Yang X-G, Wang F et al (2019) Prognostic discrepancy on overall survival between ambulatory and nonambulatory patients with metastatic spinal cord compression. World Neurosurg 121:e322–e332. https://doi.org/10.1016/j.wneu.2018.09.102
Quraishi NA, Ahmed MS, Arealis G et al (2019) Does surgical site infection influence neurological outcome and survival in patients undergoing surgery for metastatic spinal cord compression? Eur Spine J 28:792–797. https://doi.org/10.1007/s00586-018-5797-4
Tarawneh AM, Pasku D, Quraishi NA (2021) Surgical complications and re-operation rates in spinal metastases surgery: a systematic review. Eur Spine J 30:2791–2799. https://doi.org/10.1007/s00586-020-06647-6
Paulino Pereira NR, Ogink PT, Groot OQ et al (2019) Complications and reoperations after surgery for 647 patients with spine metastatic disease. Spine J 19:144–156. https://doi.org/10.1016/j.spinee.2018.05.037
Chanbour H, Chen JW, Gangavarapu LS et al (2023) Unplanned readmission is associated with decreased overall survival and performance after metastatic spine surgery. Spine 48:653–663. https://doi.org/10.1097/BRS.0000000000004596
von Elm E, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453–1457. https://doi.org/10.1016/S0140-6736(07)61602-X
Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655
Katagiri H, Okada R, Takagi T et al (2014) New prognostic factors and scoring system for patients with skeletal metastasis. Cancer Med 3:1359–1367. https://doi.org/10.1002/cam4.292
Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications. Ann Surg 240:205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae
Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660
Giordano SH, Buzdar AU, Smith TL et al (2004) Is breast cancer survival improving? Cancer 100:44–52. https://doi.org/10.1002/cncr.11859
Birgisson H, Talbäck M, Gunnarsson U et al (2005) Improved survival in cancer of the colon and rectum in Sweden. EJSO 31:845–853. https://doi.org/10.1016/j.ejso.2005.05.002
Barzilai O, Laufer I, Yamada Y et al (2017) Integrating evidence-based medicine for treatment of spinal metastases into a decision framework: neurologic, oncologic, mechanicals stability, and systemic disease. J Clin Oncol 35:2419–2427. https://doi.org/10.1200/JCO.2017.72.7362
Miyazaki S, Kakutani K, Sakai Y et al (2017) Quality of life and cost-utility of surgical treatment for patients with spinal metastases: prospective cohort study. Int Orthop 41:1265–1271. https://doi.org/10.1007/s00264-017-3463-9
Tokuhashi Y, Matsuzaki H, Oda H et al (2005) A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 30:2186–2191. https://doi.org/10.1097/01.brs.0000180401.06919.a5
Kumar N, Madhu S, Bohra H et al (2020) Is there an optimal timing between radiotherapy and surgery to reduce wound complications in metastatic spine disease? A systematic review. Eur Spine J 29:3080–3115. https://doi.org/10.1007/s00586-020-06478-5
Okafor R, Molinari W, Molinari R, Mesfin A (2016) Intrawound vancomycin powder for spine tumor surgery. Glob Spine J 6:207–211. https://doi.org/10.1055/s-0035-1558655
Barzilai O, Robin AM, O’Toole JE, Laufer I (2020) Minimally invasive surgery strategies: changing the treatment of spine tumors. Neurosurg Clin N Am 31:201–209. https://doi.org/10.1016/j.nec.2019.11.003
Tan T, Lee H, Huang MS et al (2020) Prophylactic postoperative measures to minimize surgical site infections in spine surgery: systematic review and evidence summary. Spine J 20:435–447. https://doi.org/10.1016/j.spinee.2019.09.013
Mesfin A, Sciubba DM, Dea N et al (2016) Changing the adverse event profile in metastatic spine surgery: an evidence-based approach to target wound complications and instrumentation failure. Spine 41(Suppl 20):S262–S270. https://doi.org/10.1097/BRS.0000000000001817
Feler J, Sun F, Bajaj A et al (2022) Complication avoidance in surgical management of vertebral column tumors. Curr Oncol Tor Ont 29:1442–1454. https://doi.org/10.3390/curroncol29030121
Ghori AK, Leonard DA, Schoenfeld AJ et al (2015) Modeling 1-year survival after surgery on the metastatic spine. Spine J 15:2345–2350. https://doi.org/10.1016/j.spinee.2015.06.061
Balain B, Jaiswal A, Trivedi JM et al (2013) The Oswestry Risk Index: an aid in the treatment of metastatic disease of the spine. Bone Joint J 95-B:210–216
Paulino Pereira NR, Janssen SJ, van Dijk E et al (2016) Development of a prognostic survival algorithm for patients with metastatic spine disease. J Bone Joint Surg Am 98:1767–1776. https://doi.org/10.2106/JBJS.15.00975
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Nicolás González-Kusjanovic, Catalina Vidal, and Mauricio Campos. The first draft of the manuscript was written by Nicolás González-Kusjanovic and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Pontificia Universidad Católica de Chile (ID approval number: 200625073).
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
González-Kusjanovic, N., Delgado Ochoa, B., Vidal, C. et al. Post-operative complications affect survival in surgically treated metastatic spinal cord compression. International Orthopaedics (SICOT) 48, 1341–1350 (2024). https://doi.org/10.1007/s00264-024-06120-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-024-06120-9